Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2025 11:30 ET | Source: Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to
November 06, 2025 10:27 ET | Source: Research and Markets

Ventricular Hypertrophy Industry Growth Report Report 2025-2035 - Advancements in Telemedicine Presenting New Avenues for Remote Patient Management

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Ventricular Hypertrophy Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035" has...
November 06, 2025 10:23 ET | Source: Research and Markets

Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players

Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Chronic Heart Failure Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering....
July 21, 2025 09:15 ET | Source: Longeveron

Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Longeveron licenses patented stem cell technology from the University of Miami.
July 21, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership TeamWill spearhead clinical...
July 08, 2025 09:15 ET | Source: Longeveron

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)

FDA approves Longeveron's Investigational New Drug (IND) application for stem cell therapy as a potential treatment for pediatric dilated cardiomyopathy.
June 17, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Elisabeth Björk as Board Member

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in obesity and cardiometabolic research, portfolio strategy development and...
April 30, 2025 07:00 ET | Source: NodThera

NodThera’s Oral NLRP3 Inhibitor NT-0796 Enhances and Sustains Weight Loss in Combination with GLP-1

Data published in Obesity journal show enhanced weight loss effect of NT-0796 when combined with semaglutide in preclinical obesity modelObese state completely reversed with 30% weight loss and...
April 21, 2025 08:30 ET | Source: SNS Insider pvt ltd

Global Chronic Disease Management Market Size to Hit USD 15.58 Billion by 2032, Driven by Rising Prevalence of Diabetes, Cardiovascular Conditions, and Cancer | SNS Insider

Austin, April 21, 2025 (GLOBE NEWSWIRE) -- According to the latest report by SNS Insider, the Chronic Disease Management Market was valued at USD 4.83 billion in 2023 and is projected to reach USD...
March 12, 2025 15:00 ET | Source: ACTG

ACTG Presents Important Findings from REPRIEVE at CROI 2025

ACTG Presents Findings from REPRIEVE at CROI 2025 Presentations Address Frailty, Inflammation, Asymptomatic Heart Muscle Damage, and Mental Function